Elicio Therapeutics (ELTX) Preferred Shares Issued (2020 - 2022)
Elicio Therapeutics posted quarterly Preferred Shares Issued of $11.1 million for Q4 2022, up 25.69% on a QoQ basis from $8.8 million in Q3 2022.
Elicio Therapeutics (ELTX) has 2 years of Preferred Shares Issued data on file, last reported at $11.1 million in Q4 2022.
- For the quarter ending Q4 2022, Preferred Shares Issued changed N/A year-over-year to $11.1 million; the trailing twelve-month figure through Dec 2023 stood at $20.0 million (changed 0.0% YoY), and the FY2022 full-year result was $21.1 million, changed N/A from the prior year.
- Preferred Shares Issued for Q4 2022 stood at $11.1 million, up from $8.8 million in the prior quarter.
- Across five years, Preferred Shares Issued topped out at $13.8 million in Q3 2020 and bottomed at $885000.0 in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Elicio Therapeutics | 217.63 Mn | 202.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 11.11 Mn |
| Dec 31, 2022 | 11.11 Mn |
| Sep 30, 2022 | 8.84 Mn |
| Sep 30, 2022 | 8.84 Mn |
| Sep 30, 2020 | 13.78 Mn |
| Sep 30, 2020 | 13.78 Mn |
| Jun 30, 2020 | 5.39 Mn |
| Jun 30, 2020 | 5.39 Mn |
| Mar 31, 2020 | 885,000.00 |
| Mar 31, 2020 | 885,000.00 |